AQR Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.09M	Buy	1,394,376 +436,797	+46%	+$2.9M	﹤0.01%	1449
2025 Q4	$7.52M	Sell	957,579 -26,021	-3%	-$205K	﹤0.01%	1346
2025 Q3	$8.01M	Sell	983,600 -65,393	-6%	-$434K	0.01%	1196
2025 Q2	$4.9M	Buy	1,048,993 +102,227	+11%	+$468K	﹤0.01%	1298
2025 Q1	$5.2M	Buy	946,766 +111,826	+13%	+$451K	0.01%	1114
2024 Q4	$2.83M	Sell	834,940 -233,176	-22%	-$750K	﹤0.01%	1341
2024 Q3	$3.04M	Sell	1,068,116 -124,964	-10%	-$321K	﹤0.01%	1289
2024 Q2	$2.68M	Buy	1,193,080 +52,074	+5%	+$105K	﹤0.01%	1327
2024 Q1	$2.52M	Buy	1,141,006 +867,784	+318%	+$2.25M	﹤0.01%	1303
2023 Q4	$642K	Buy	273,222 +230,942	+546%	+$426K	﹤0.01%	1778
2023 Q3	$78.6K	Buy	42,280 +28,612	+209%	+$65.5K	﹤0.01%	2254
2023 Q2	$35.8K	Sell	13,668 -17,898	-57%	-$45.6K	﹤0.01%	2169
2023 Q1	$51.5K	Sell	31,566 -18,688	-37%	-$23.4K	﹤0.01%	2142
2022 Q4	$66.8K	Buy	50,254 +29,712	+145%	+$41.9K	﹤0.01%	2162
2022 Q3	$32K	Buy	+20,542	New	+$34K	﹤0.01%	2159